Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Autolus Therapeutics Announced The Pricing Of An Underwritten Offering In The United States Of 58,333,336 American Depositary Shares (ADSs) Representing 58,333,336 Ordinary Shares At A $6.00 Per ADS, For Total Gross Proceeds Of $350M

Author: Benzinga Newsdesk | February 08, 2024 08:05am

Posted In: AUTL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist